Sensifree
21631 Stevens Creek Boulevard
Cupertino
California
95014
United States
Tel: 1-408-913-5574
Website: http://www.sensifree.com/
About Sensifree
Sensifree is a medical device company, on a mission to revolutionize how patients are cared for in hospitals. We develop continuous, noninvasive hemodynamic monitoring solutions, based on our proprietary NEST™ (Noninvasive Electromagnetic Sensing Technology) platform. Our first product provides continuous blood pressure monitoring for patients admitted in the ICU, undergoing surgery or recovering from procedures. This product offers beat-to-beat reading and waveform display as the invasive arterial line, without the risks and costs associated with it.
YEAR FOUNDED:
2012
LEADERSHIP:
Founders: Eran Agmon and Ilan Barak
Founder and CEO: Eran Agmon
Founder and CTO: Ilan Barak
COO: Lior Haviv
JOBS:
4 articles about Sensifree
-
Sensifree Wins CE Certification for SentiCor-100® Continuous Non-Invasive Blood Pressure Monitor
8/31/2022
Sensifree LTD, a world innovator in advanced hemodynamic monitoring, received CE certificate for SentiCor-100® in compliance with the new EU MDR.
-
BIRD Foundation Awards Grant to Sensifree and Cleveland Clinic to Develop Continuous Non-Invasive Blood Pressure Monitor
2/8/2022
Sensifree LTD, a medical device company developing advanced patient monitoring solutions, announced the launch of a joint development program supported by the BIRD Foundation, with Cleveland Clinic.
-
Sensifree and Dreamtech Partner on Product Development Supported by the KORIL-RDF Foundation
8/11/2020
Sensifree LTD announced that Sensifree and Dreamtech Co., LTD have launched a joint development program supported by the Korea-Israel Research and Development Foundation, to develop an innovative non-invasive blood pressure and other vital signs monitoring solutions for professional use.
-
Sensifree Reports Statistically Significant Concordance of Arterial Pressure Signal Waveform Between its Continuous Non-invasive Blood Pressure Monitoring Technology and Invasive Arterial Line
1/5/2018
Preliminary results demonstrate accurate tracking of systolic and diastolic pressure values.